Opportunities
Search

Buyer: Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-11-09

Buyer: DREAL Nouvelle-Aquitaine | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-11-09

Buyer: Stichting Keender | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-09

Buyer: COMUNE DI PIACENZA | Notice type: cn-standard | Contract: services | Deadline: 2026-11-09

Buyer: Oslo Kommune Munchmuseet | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2026-11-09

Buyer: Junta de Gobierno del Ayuntamiento de Molina de Segura | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2026-11-09

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for the conduct of scientific research utilizing data from expanded access (EA) for investigational drugs or biological products as described in section 561 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb). These applications will target intermediate size populations of patients living with amyotrophic lateral sclerosis (ALS) who are not eligible for ongoing clinical trials for the prevention, diagnosis, mitigation, treatment, or cure of ALS.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites grant applications proposing exploratory research projects focused on further development and technical validation of emerging technologies offering novel capabilities for the molecular or cellular characterization of cancer or for improved handling and quality control of biospecimens used for basic, clinical, or epidemiological cancer research. This NOFO solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still require further development and rigorous technical validation to encourage adoption by the research community. Well-suited applications must propose the development of technologies that offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, cancer control, epidemiology. Technologies proposed for development may have potential for widespread applicability but must be focused in this proposal on cancer-relevant use cases. Projects proposing to apply or use existing technologies for hypothesis-driven research where the novelty resides in the biological or clinical target/question being pursued are not responsive to this solicitation and will not be reviewed.This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to develop innovative technologies offering new capabilities for the molecular or cellular characterization of cancer or for improved handling and quality control of biospecimens for basic, clinical, or epidemiological cancer research. The NOFO solicits R61 applications for early-stage projects proposing proof-of-concept/pilot studies to test the technical feasibility of the proposed method, tool, assay, platform, or instrument. Technologies proposed for development may have potential for widespread applicability but must be focused for this program on cancer-relevant use cases. Projects proposing to apply or use existing technologies for hypothesis-driven research where the novelty resides in the biological or clinical target/question being pursued are not responsive to this solicitation and will not be reviewed.This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.

NOTICE: Amended July 21, 2026. This amendment adds to ROSES-2025 this program element which was previously listed as not solicited this year. Proposals are due November 10, 2026. New this year: no Step-1 or Notice of Intent is requested. New this year: Proposals to this program element will be evaluated using a dual-anonymous peer review process. See guidelines in Section 3.13 of C.1, and in the associated "Guidelines for Anonymous Proposals" document under "Other Documents" on the NSPIRES page for this program element for the preparation of anonymous proposals. NOTICE: Research security training required starting August 5, 2026. All PIs and any Co-Is that would spend ≥ 10% time on a proposed grants or cooperative agreements must certify they have taken research security training. NASA will be satisfied with the four online research security training modules on the National Science Foundation's (NSF) Research Security Training website at https://www.nsf.gov/research-security/training or the SECURE Center condensed version of the four modules at https://www.secure-center.org/ctm NOTICE: ROSES-25 Amendment 7 makes the following changes to C.1 the Planetary Research Overview: It establishes funding threshold and submission requirements for substantial instrument or equipment requests (Section 3.11), removes the estimated page limit for pilot studies (Section 3.4) and clarifies text on use of spacecraft mission data (Section 3.5). New text is in bold and deleted text is struck through. A Planetary Science Overview FAQ has been posted under other documents on NSPIRES pages for a...

Buyer: Office fédéral des routes OFROU, Division Infrastructure routière Ouest, filiale Estavayer-le-Lac | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-11-10

Buyer: Presidencia de la Entidad Valenciana de Vivienda y Suelo | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-11-10

Buyer: Alliander N.V. | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-11-10

Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-10

Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-10

Buyer: Miejskie Przedsiębiorstwo Wodociągów i Kanalizacji S.A. | Notice type: pin-rtl | Contract: supplies | Deadline: 2026-11-10

Buyer: Stockholms läns sjukvårdsområde | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2026-11-10

Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-10

Buyer: Centre Hospitalier Alpes Léman, établissement support du GHT Léman Mont-Blanc | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-10

Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-10

Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-10

Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-10

Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-10

Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-10

Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-10